MICROSCOPIC POLYANGIITIS
Clinical trials for MICROSCOPIC POLYANGIITIS explained in plain language.
Never miss a new study
Get alerted when new MICROSCOPIC POLYANGIITIS trials appear
Sign up with your email to follow new studies for MICROSCOPIC POLYANGIITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cheaper version of vasculitis drug works just as well, study finds
Disease control CompletedThis study looked at 201 Canadian patients with ANCA-associated vasculitis to see if a cheaper biosimilar version of rituximab works as well as the original drug. Researchers compared how well the drugs controlled the disease, side effects, and how long patients waited for approv…
Matched conditions: MICROSCOPIC POLYANGIITIS
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated May 17, 2026 11:38 UTC
-
Smart dosing of rituximab may prevent relapses in rare vasculitis
Disease control CompletedThis study tested whether giving the drug rituximab based on blood markers (ANCA and CD19 cells) works better than giving it on a fixed schedule to prevent relapses in people with ANCA-associated vasculitis. 166 adults who were already in remission took part. The goal was to see …
Matched conditions: MICROSCOPIC POLYANGIITIS
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated May 17, 2026 11:36 UTC
-
Can a single drug keep rare blood vessel disease at bay?
Disease control CompletedThis study looked at whether rituximab can help people with a rare autoimmune disease called ANCA-associated vasculitis stay in remission longer than the standard treatment, azathioprine. 117 adults who were already in remission took either rituximab or azathioprine for 18 months…
Matched conditions: MICROSCOPIC POLYANGIITIS
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Could a low-dose alcoholism drug ease vasculitis symptoms?
Symptom relief CompletedThis study tested whether a very low dose of naltrexone, a drug normally used for alcoholism, can improve physical health and quality of life in people with vasculitis (a group of rare blood vessel diseases). Sixty adults with different types of vasculitis took either the low-dos…
Matched conditions: MICROSCOPIC POLYANGIITIS
Phase: PHASE2 • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated May 17, 2026 11:34 UTC